
Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer
Author(s) -
LucieMarie Scailteux,
Florian Naudet,
Q. Alimi,
S. Vincendeau,
Emmanuel Oger
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000003873
Subject(s) - medicine , androgen deprivation therapy , prostate cancer , relative risk , placebo , myocardial infarction , randomized controlled trial , antiandrogen , observational study , stroke (engine) , meta analysis , oncology , cancer , confidence interval , pathology , mechanical engineering , alternative medicine , engineering
Supplemental Digital Content is available in the text